Molecular evidence of a dominant multidrug resistant Acinetobacter baumannii lineage in a tertiary hospital in northern Peru

Background

Acinetobacter baumannii is a major nosocomial pathogen because of its genomic plasticity and capacity to acquire multidrug resistance (MDR), particularly resistance to carbapenems. The World Health Organization classifies carbapenem-resistant A. baumannii as a critical-priority pathogen. Molecular epidemiological data from Latin America remain limited, especially for northern Peru.

Methods